Reference 7 - Incorporation of excess gadolinium into human bone from medical contrast agents

NonrulemakingSupporting & Related MaterialFDA-2026-P-6737-0009
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 15, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets